Up a level |
Number of items: 1.
McClurg, Urszula L ORCID: 0000-0003-2631-4174, Azizyan, Mahsa, Dransfield, Daniel T, Namdev, Nivedita, Chit, Nay CTH, Nakjang, Sirintra and Robson, Craig N
(2018)
The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survival.
Oncotarget, 9 (38).
pp. 24992-25007.